Lumenis Be. Ltd., a leading energy-based medical device company, unveiled the latest edition of its groundbreaking multi-application aesthetic platform, the Stellar M22™ with XPL™ Technology, powered by four cutting-edge technologies and approved to treat over 30 different indications. Stellar M22™ enables versatile treatment workflows and outstanding patient outcomes, for any age, gender, and skin type — all in one compact system. Underscoring its clinical impact, Lumenis showcased positive clinical data at the 2025 Annual American Society for Dermatologic Surgery (ASDS) Meeting, demonstrating the platform's unparalleled ability to achieve at least a 70 per cent improvement in just a single XPL session.
From the inventors and pioneers of the IPL therapy approach, the gold standard of photo rejuvenation since 1993, Stellar M22™ with XPL™ is designed for aesthetics professionals committed to delivering best-in-class treatments and showcasing their full expertise through elevated versatility. As the multi-billion-dollar energy-based skincare market continues its explosive growth, Stellar M22™ sets a new standard for multi-application platforms, building upon the legacy of 30,000+ installations across multiple device generations worldwide.
Key system innovations include:
XPL™ (Expert Pulsed Light) Technology: Latest advancement in pulsed light technology featuring 8 expert filters, sub-pulsing technology, and Advanced Pulse Design for broad versatility and precision control of each variable of the pulse parameters
XPL™ Glide Mode: NEW feature enabling precise, faster treatments in motion with increased comfort and high-speed passes — suitable for skin rejuvenation treatments and coverage of larger treatment areas
Diverse Treatment Modalities: Addresses uneven skin tone and texture improvement, large vascular lesions, and dark tattoo removal
ResurFX® BrushFX™ Mode: NEW capability delivering natural-looking texture effects with refined, air-brush style blending for seamless aesthetic finishes
Hybrid treatment modalities: Featuring unique treatments such as PhotoFABULOUS™ which combines two leading Stellar technologies - XPL and ResurFX for complete skin rejuvenation, and SmoothGlo™ which pairs two of Lumenis's leading systems – Stellar XPL and triLift RF Microneedling for improvement is skin texture, tone, and volume
850+ Built-in Expert Protocols: Simplifies delegation and ensures repeatable, consistent outcomes across treatment teams
"At Lumenis, innovation is at the heart of everything we do, and the new Stellar M22 with XPL™ Technology is a shining example of that commitment. This powerful, multi-application platform meets the evolving needs of today's aesthetic providers, offering unparalleled versatility and clinically proven efficacy across a wide range of skin concerns," said Tzipi Ozer-Armon, CEO of Lumenis. "With Stellar M22, we're not just delivering a platform — we're providing a transformative tool that elevates clinical practice and empowers patients to look and feel their best."
